Citadel Advisors’s Eucrates Biomedical Acquisition Corp. Warrant EUCRW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-18,173
Closed -$736 6836
2023
Q1
$736 Buy
+18,173
New +$736 ﹤0.01% 5782